glp-1/gip dual agonist lilly The FDA approved a new GLP-1 pill for weight loss from Eli on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' @DrLaPook has more on the new medication I guess most people haven't

The National Family Health Survey (NFHS-4, 2015-16) reported that 20.7% of women and 18.6% of men in the 15-49 age group were overweight or obese, underscoring the urgent need for effective weight-loss solutions

Canadian Journal of Diabetes, 2017, 41(5): 524-535

Routine clinical use of liraglutide 3 mg for the treatment of obesity: outcomes in non-surgical and bariatric surgery patients

Preliminary data point toward beneficial effects of GIP agonism, as reported in findings from the SURPASS program that tirzepatide reduced UACR and slowed down eGFR declined in comparison with both placebo (53) and comparator drugs including insulin glargine (74, 75)

eClinicalMedicine 37:100895